SEATTLE and TOKYO — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Riken Genesis, a subsidiary of Sysmex Corporation (TOKYO, 6869), today announced that they have entered into a partnership to  introduce nCounter-based diagnostic assays in Japan. Under this agreement, NanoString and Riken Genesis will collaborate to register, obtain reimbursement and […]

Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that it has entered into a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) focused on optimizing BLI’s proprietary BeaconTMOptofluidic platform with the goal of helping to accelerate Pfizer’s monoclonal antibody (mAb) […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “Atlanta Biologicals is a great fit with the Bio-Techne […]

ACEA Biosciences makes available an exhaustive library of xCELLigence papers spanning 15 years and applications ranging from immune cell killing and cell invasion/migration to viral cytopathic effect and cardiotoxicity screening SAN DIEGO In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell […]

One year. Five new products. 2017 marked another record year for new product launches at Stratedigm. And CellCapTure 4.1—our flow cytometry acquisition and analysis software—is the foundation of Stratedigm’s latest innovations. Never before have such revolutionary products like the patent pending Visual Protocol Designer (VPD), Universal-API for automation, IoT empowered Control Center, and the A800 Cell Incubator (CI) been seamlessly integrated in […]

Madison, WI – Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSC-cells, announced that its iCell® Cardiomyocytes were launched into space via SpaceX’s 13th commercial resupply services mission to the International Space Station on Dec.15, 2017. The purpose of the scientific research […]

WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]

TOKYO – JSR Corporation agreed with Crown Bioscience International (hereinafter “Crown”, Registration: Cayman Islands, CEO:Jean-Pierre Wery, a listed company in TPEx: 6554), which is a contract research organization (“CRO”) providing services to pharmas to support drug development in pre-clinical phases, to acquire 100% ownership of the Company and make it a subsidiary of JSR (the […]

To further enhance Cellectricon’s expertise in Chronic Pain drug discovery, the company is today announcing the addition of another highly respected specialist, Professor Camilla Svensson, to its scientific advisory board. Professor Svensson obtained her PhD at UC San Diego, where she also held a postdoctoral research position at the Department of Medicine. She subsequently moved […]